메뉴 건너뛰기




Volumn 408, Issue 1-2, 2009, Pages 143-144

Analytical assay characterization for 1-108Pro-B-type natriuretic peptide on the BioPlex™ 2200 analyzer

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETIC ACID;

EID: 69849105338     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.08.003     Document Type: Letter
Times cited : (10)

References (15)
  • 1
    • 1342312435 scopus 로고    scopus 로고
    • Essential biochemistry and physiology of (NT-pro)BNP
    • Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6 (2004) 257-260
    • (2004) Eur J Heart Fail , vol.6 , pp. 257-260
    • Hall, C.1
  • 2
    • 12444278136 scopus 로고    scopus 로고
    • Characterization of molecular forms of probrain natriuretic peptide in human plasma
    • Shimizu H., Masuta K., Asada H., Sugita K., and Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 334 (2003) 233-239
    • (2003) Clin Chim Acta , vol.334 , pp. 233-239
    • Shimizu, H.1    Masuta, K.2    Asada, H.3    Sugita, K.4    Sairenji, T.5
  • 3
    • 33847358624 scopus 로고    scopus 로고
    • Evidence for functional heterogeneity of circulating B-type natriuretic peptide
    • Liang F., O'Rear J., Schellenberger U., et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 49 (2007) 1071-1078
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1071-1078
    • Liang, F.1    O'Rear, J.2    Schellenberger, U.3
  • 4
    • 34247842790 scopus 로고    scopus 로고
    • Immunoreactivity and guanosine 3′, 5′-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide
    • Heublein D.M., Huntley B.K., Boerrigter G., et al. Immunoreactivity and guanosine 3′, 5′-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension 49 (2007) 1114-1119
    • (2007) Hypertension , vol.49 , pp. 1114-1119
    • Heublein, D.M.1    Huntley, B.K.2    Boerrigter, G.3
  • 5
    • 40449126121 scopus 로고    scopus 로고
    • Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage
    • Luckenbill K.N., Christenson R.H., Jaffe A.S., et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 54 (2008) 619-621
    • (2008) Clin Chem , vol.54 , pp. 619-621
    • Luckenbill, K.N.1    Christenson, R.H.2    Jaffe, A.S.3
  • 6
    • 33646916875 scopus 로고    scopus 로고
    • Assay for measurement of intact B-type natriuretic peptide prohormone in blood
    • Giuliani I., Rieunier F., Larue C., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 52 (2006) 1054-1061
    • (2006) Clin Chem , vol.52 , pp. 1054-1061
    • Giuliani, I.1    Rieunier, F.2    Larue, C.3
  • 7
    • 42949169040 scopus 로고    scopus 로고
    • Pro-B-type natriuretic peptide levels in acute decompensated heart failure
    • Waldo S.W., Beede J., Isakson S., et al. Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 51 (2008) 1874-1882
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1874-1882
    • Waldo, S.W.1    Beede, J.2    Isakson, S.3
  • 8
    • 84895779668 scopus 로고    scopus 로고
    • Defining, establishing, and verifying reference intervals in the clinical laboratory. Approved guidelines
    • Clinical and Laboratory Standards Institute Wayne, PA
    • Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory. Approved guidelines. CLSI document C28-A3. 3rd ed. (2008) Wayne, PA
    • (2008) CLSI document C28-A3. 3rd ed.
  • 9
    • 58149218177 scopus 로고    scopus 로고
    • Short- and long-term biological variation in cardiac troponin I with a high-sensitivity assay: implications for clinical practice
    • Wu A.H.B., Lu A., Todd J., Moecks J., and Wians F. Short- and long-term biological variation in cardiac troponin I with a high-sensitivity assay: implications for clinical practice. Clin Chem 55 (2009) 52-58
    • (2009) Clin Chem , vol.55 , pp. 52-58
    • Wu, A.H.B.1    Lu, A.2    Todd, J.3    Moecks, J.4    Wians, F.5
  • 10
    • 57049124829 scopus 로고    scopus 로고
    • Interpretation of creatine kinase and aldolase for statin-induced myopathy: reliance on serial testing based on biological variation
    • Wu A.H.B., Smith A., and Wians F.H. Interpretation of creatine kinase and aldolase for statin-induced myopathy: reliance on serial testing based on biological variation. Clin Chim Acta 399 (2009) 109-111
    • (2009) Clin Chim Acta , vol.399 , pp. 109-111
    • Wu, A.H.B.1    Smith, A.2    Wians, F.H.3
  • 11
    • 0024342985 scopus 로고
    • Generation and application of data on biological variation in clinical chemistry
    • Fraser C.G., and Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27 (1989) 409-437
    • (1989) Crit Rev Clin Lab Sci , vol.27 , pp. 409-437
    • Fraser, C.G.1    Harris, E.K.2
  • 12
    • 33746605983 scopus 로고    scopus 로고
    • Reference change values for brain natriuretic peptides revisited
    • Fokkema M.R., Herrmann Z., Muskiet F.A., and Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 52 (2006) 1602-1603
    • (2006) Clin Chem , vol.52 , pp. 1602-1603
    • Fokkema, M.R.1    Herrmann, Z.2    Muskiet, F.A.3    Moecks, J.4
  • 13
    • 28444443740 scopus 로고    scopus 로고
    • Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure
    • Hawkridge A.M., Heublein D.M., Bergen III H.R., Cataliotti A., Burnett Jr. J.C., and Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA 102 (2005) 17442-17447
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 17442-17447
    • Hawkridge, A.M.1    Heublein, D.M.2    Bergen III, H.R.3    Cataliotti, A.4    Burnett Jr., J.C.5    Muddiman, D.C.6
  • 14
    • 27144449108 scopus 로고    scopus 로고
    • Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension
    • Dries D.L., Victor R.G., Rame J.E., et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112 (2005) 2403-2410
    • (2005) Circulation , vol.112 , pp. 2403-2410
    • Dries, D.L.1    Victor, R.G.2    Rame, J.E.3
  • 15
    • 34247135389 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study
    • Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49 (2007) 1733-1739
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1733-1739
    • Jourdain, P.1    Jondeau, G.2    Funck, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.